Beam Therapeutics Inc.
BEAM
$26.75
$0.240.91%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -85.43M | -64.89M | -78.90M | -413.55M | -397.49M |
| Total Depreciation and Amortization | 22.24M | 22.37M | 22.29M | 22.07M | 21.98M |
| Total Amortization of Deferred Charges | 99.00K | 35.00K | -- | -- | -- |
| Total Other Non-Cash Items | -159.91M | -166.09M | -157.48M | 103.21M | 99.06M |
| Change in Net Operating Assets | -136.38M | -161.16M | -131.02M | -49.91M | -68.38M |
| Cash from Operations | -359.38M | -369.73M | -345.10M | -338.18M | -344.82M |
| Capital Expenditure | -13.39M | -14.11M | -14.95M | -14.18M | -10.75M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -78.00K | -78.00K | -78.00K | -78.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 202.93M | 43.11M | -106.41M | -89.31M | -133.77M |
| Cash from Investing | 189.46M | 28.92M | -121.44M | -103.57M | -144.52M |
| Total Debt Issued | 93.89M | 93.89M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -201.00K |
| Issuance of Common Stock | 14.62M | 8.21M | 478.05M | 479.61M | 479.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -813.00K | -813.00K | -- | -- | -- |
| Cash from Financing | 107.69M | 101.28M | 478.05M | 479.61M | 479.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.23M | -239.53M | 11.51M | 37.86M | -10.15M |